Showing results (1131-1140 of 1,326) with videos related to
Sort By:
Pageof 133
Psychiatry Research. Neuroimaging|January 28, 2023
Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesityHartej Gill, Roger S McIntyre, Colin Hawco, et al.BMC Psychiatry|May 14, 2025
Association between living arrangement and psychological well-being among patients with major depressive disorder: the moderating role of body mass indexChengxi Wen, Yifeng Liu, Yanzhi Li, et al.Journal of Psychopharmacology (Oxford, England)|November 15, 2022
Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorderHouman Rashidian, Mehala Subramaniapillai, Caroline Park, et al.Journal of Affective Disorders|February 1, 2026
The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analysesHana Ballum, Christine Dri, Sonya Liao, et al.Psychiatry Research|December 10, 2021
Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.Psychiatry Research|July 10, 2021
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemicJoshua D Rosenblat, Orly Lipsitz, Joshua D Di Vincenzo, et al.Expert Opinion on Drug Safety|April 15, 2022
Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatmentMarcus A Doyle, Susan Ling, Leanna M W Lui, et al.Current Medical Research and Opinion|July 2, 2024
Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysisSonya Liao, Kayla M Teopiz, Angela T H Kwan, et al.CNS Spectrums|May 26, 2025
Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implicationsKayla M Teopiz, Heidi K Y Lo, Moiz Lakhani, et al.Journal of Affective Disorders|January 10, 2021
Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorderHouman Rashidian, Mehala Subramaniapillai, Caroline Park, et al.Pageof 133